Rebecca Schennach-Wolff

Author PubWeight™ 10.46^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Response and remission criteria in major depression--a validation of current practice.	J Psychiatr Res	2010	1.52
2	Is the PANSS used correctly? a systematic review.	BMC Psychiatry	2011	1.22
3	Celecoxib treatment in an early stage of schizophrenia: results of a randomized, double-blind, placebo-controlled trial of celecoxib augmentation of amisulpride treatment.	Schizophr Res	2010	1.22
4	Should the PANSS be rescaled?	Schizophr Bull	2009	0.99
5	Clinical predictors of response and remission in inpatients with depressive syndromes.	J Affect Disord	2011	0.89
6	Safety evaluation of zotepine for the treatment of schizophrenia.	Expert Opin Drug Saf	2010	0.87
7	Do efficacy and effectiveness samples differ in antidepressant treatment outcome? An analysis of eligibility criteria in randomized controlled trials.	J Clin Psychiatry	2010	0.85
8	Does early improvement in major depression protect against treatment emergent suicidal ideation?	J Affect Disord	2009	0.80
9	Effectiveness of quetiapine in outpatients with schizophrenia assessed under "real-life" conditions: a German clinical-practice evaluation programme.	J Clin Psychopharmacol	2011	0.78
10	Depressive symptoms and their association with acute treatment outcome in first-episode schizophrenia patients: comparing treatment with risperidone and haloperidol.	World J Biol Psychiatry	2011	0.77
11	Review: antidepressants associated with increased risk of suicidality in adults aged less than 25 years.	Evid Based Ment Health	2010	0.75